The Smart Money Is Buying These 10 Stocks

An analysis suggests that mimicking the public equity investments of private equity firms like KKR, Apollo, and Blackstone has historically outperformed the market, with a 4-to-1 margin since 2001. KKR's top ten holdings include firms across healthcare, real estate, sports, and pharmaceuticals, reflecting a value investing approach augmented with debt financing. The strategy focuses on identifying undervalued assets and leveraging debt to enhance returns, offering potential opportunities for investors who track these firms' quarterly filings.

Analysis

The strategy of replicating public equity investments disclosed in quarterly 13F filings by private equity firms such as Apollo Global Management (APO), Blackstone (BX), and KKR & Co. Inc. (KKR) has historically demonstrated significant market outperformance, reportedly by a 4-to-1 margin since 2001. This investment approach typically combines principles of value investing with the strategic application of debt to amplify returns. KKR's public portfolio, for instance, has previously generated substantial returns from holdings like Mr. Cooper (COOP), AppLovin (APP), and DoorDash (DASH). KKR's current top ten public holdings showcase a diversified strategy across multiple sectors: healthcare is represented by BrightSpring Health Services (BTSG), targeting demographic tailwinds and growth through acquisitions, and BridgeBio Pharma (BBIO), which has seen its drug Attruby significantly outperform sales expectations post-approval in late 2024. Henry Schein (HSIC) offers stable cash flow in dental and medical supplies, while BrightView (BV) is undergoing a restructuring to improve margins. KKR Real Estate Finance Trust (KREF) provides a high dividend yield but faces office market and refinancing risks. Madison Square Garden Sports (MSGS) offers a unique play on sports franchise appreciation. Norwegian Cruise Line (NCLH) is rebounding post-pandemic but carries significant leverage. Bausch Health (BHC) is pursuing a turnaround amid high debt and legal overhangs. FS KKR (FSK), a business development company, offers a high yield with sponsor backing, requiring credit quality monitoring. Crescent Energy (CSGY) is positioned as a defensive upstream energy play. The overall positive sentiment score of 0.6 associated with this approach underscores continued investor interest in these PE-led public market strategies.

Key Decisions for Investors

• Investors should consider monitoring the quarterly 13F filings of leading private equity firms like KKR to identify potential investment ideas, given the documented historical outperformance of strategies that emulate these institutional holdings.
• A detailed individual assessment of KKR's current top holdings is crucial, balancing potential upsides, such as BridgeBio Pharma's (BBIO) strong drug launch (ticker sentiment 0.6), against specific risks like Bausch Health's (BHC) significant debt burden (ticker sentiment -0.4) or BrightView's (BV) ongoing restructuring efforts (ticker sentiment -0.2).
• It is important to recognize that the value-plus-leverage strategy employed by private equity firms can magnify both returns and risks; therefore, careful due diligence on company-specific fundamentals, leverage levels (e.g., NCLH, BHC), and sector-specific challenges (e.g., commercial real estate for KREF) is warranted before making investment decisions.